The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
Editor’s Note: This deep dive was originally published Sept. 24, 2025, as a special edition of Biopharm Executive. Subscribe ...
A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...
The U.S. has ceded its leadership in critical industries before. It must not do so with China and biotech now, writes the ...
SEARCA, UPLB-Biotech lead dialogue to accelerate registration of microbial-based products in academe
In a move to drive innovation and regulatory responsiveness in agricultural biotechnology, the Southeast Asian Regional ...
CSL (ASX:CSL) has attracted fresh attention after its Broadmeadows plasma fractionation facility in Australia was named the ...
1.1a Congress must establish a National Biotechnology Coordination Office (NBCO) within the Executive Office of the President with a director, appointed by the President, who would coordinate ...
The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...
As the EU prepares its first Biotech Act, experts say that Europe risks overlooking the role of biotechnology in food, a gap ...
11hon MSN
Bharat Biotech forays into CRDMO space with new cell & gene therapies arm Nucelion Therapeutics
Bharat Biotech is venturing into advanced therapies by launching Nucelion Therapeutics, a subsidiary focused on cell and gene ...
The Department of Biotechnology is creating regional innovation hubs and 'Bio E3 Cells' to build a stronger national ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback